IGC

IGC Pharma (IGC)

IGC Pharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:IGC

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/11/25	22 : 30	Business Wire	IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment	AMEX:IGC	IGC Pharma Inc
2024/11/13	06 : 04	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:IGC	IGC Pharma Inc
2024/09/28	05 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:IGC	IGC Pharma Inc
2024/09/28	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:IGC	IGC Pharma Inc
2024/09/18	21 : 00	Business Wire	IGC Pharma Announces Additional Data Supporting IGC-AD1 as an Alzheimer's Treatment	AMEX:IGC	IGC Pharma Inc
2024/09/04	21 : 00	Business Wire	IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer's Disease	AMEX:IGC	IGC Pharma Inc
2024/08/27	08 : 00	Business Wire	IGC Announces Results of its 2024 Annual Stockholders Meeting	AMEX:IGC	IGC Pharma Inc
2024/08/22	22 : 00	Business Wire	IGC Pharma Announces Research Demonstrating New Molecule IGC-1C Targets Tau Protein in Alzheimer's Disease	AMEX:IGC	IGC Pharma Inc
2024/08/20	21 : 00	Business Wire	IGC Pharma Expands Drug Portfolio to Metabolic Disorders with IGC-1A, A Potential New GLP-1 Agonist	AMEX:IGC	IGC Pharma Inc
2024/08/15	05 : 23	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	AMEX:IGC	IGC Pharma Inc
2024/08/09	10 : 30	Business Wire	IGC Pharma Reports First Quarter Fiscal 2025 Results	AMEX:IGC	IGC Pharma Inc
2024/08/08	05 : 03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:IGC	IGC Pharma Inc
2024/08/03	03 : 38	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:IGC	IGC Pharma Inc
2024/07/18	22 : 00	Business Wire	IGC Pharma Announces Equity Analyst Coverage by Alliance Global Partners (AGP) with a "Buy" Recommendation and $3.50 Price Target	AMEX:IGC	IGC Pharma Inc
2024/07/10	03 : 17	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	AMEX:IGC	IGC Pharma Inc
2024/07/09	22 : 10	Business Wire	Preclinical Analyses of TGR-63 Demonstrate Blood-Brain Barrier Permeability and Safety Profile	AMEX:IGC	IGC Pharma Inc
2024/07/09	05 : 07	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	AMEX:IGC	IGC Pharma Inc
2024/06/25	22 : 00	Business Wire	IGC Pharma's TGR-63 Preclinical Results Show Substantial Reduction in Amyloid Plaque, a Key Hallmark of Alzheimer's Disease	AMEX:IGC	IGC Pharma Inc
2024/06/25	08 : 30	Business Wire	IGC Reports Financial Results for Fiscal Year Ended March 31, 2024	AMEX:IGC	IGC Pharma Inc
2024/06/18	22 : 00	Business Wire	IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets	AMEX:IGC	IGC Pharma Inc
2024/06/10	22 : 00	Business Wire	IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol	AMEX:IGC	IGC Pharma Inc
2024/05/28	22 : 00	Business Wire	IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1	AMEX:IGC	IGC Pharma Inc
2024/05/22	10 : 20	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	AMEX:IGC	IGC Pharma Inc
2024/05/22	03 : 00	Business Wire	IGC Pharma to Attend BIO International Convention 2024	AMEX:IGC	IGC Pharma Inc
2024/05/14	10 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:IGC	IGC Pharma Inc
2024/05/14	10 : 53	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:IGC	IGC Pharma Inc
2024/04/16	20 : 00	Business Wire	IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two	AMEX:IGC	IGC Pharma Inc
2024/04/09	22 : 00	Business Wire	IGC Pharma Adds Advisor in Artificial Intelligence	AMEX:IGC	IGC Pharma Inc
2024/03/27	04 : 00	Business Wire	IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock	AMEX:IGC	IGC Pharma Inc
2024/03/21	00 : 00	Business Wire	IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation	AMEX:IGC	IGC Pharma Inc